ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 243

The Association Between Metabolic Syndrome and Hand Osteoarthritis – Data From The Framingham Study

Ida K. Haugen1, Vasan Ramachandran2,3, Devyani Misra4, Tuhina Neogi4, Jingbo Niu4, Yuqing Zhang5 and David T. Felson5, 1Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Section of Preventive Medicine and Epidemiology, Boston University School of Medicine, Boston, MA, 3Cardiology, Boston University School of Medicine, Boston, MA, 4Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 5Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Epidemiologic methods, Hand disorders, Lipids, metabolic syndrome and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis - Clinical Aspects I: Risk Factors for and Sequelae of Osteoarthritis.

Session Type: Abstract Submissions (ACR)

Background/Purpose: Metabolic factors may have a negative effect on cartilage, and may be especially relevant in the pathogenesis of hand OA. Our aim was to investigate whether metabolic syndrome and its components were associated with prevalent and incident hand OA in a large community-based sample.

Methods: We included participants from the Framingham Offspring cohort, who were examined for OA at exam 5 (1991-95) and 7 (1998-2001). Inclusion criteria were: available data on symptomatic hand OA, clinical data, no anti-hypertensive, anti-diabetic and lipid-lowering treatment, no rheumatoid arthritis, and age 50-75 years at exam 5. Symptomatic hand OA was defined as Kellgren-Lawrence grade ≥2 and pain in the same joint(s). Metabolic syndrome was defined as central obesity (men: ≥37.0 inches, women: ≥31.5 inches waist circumference) plus two of the following: hypertension (systolic ³130 mmHg and/or diastolic ³85 mmHg), elevated fasting blood glucose (>100 mg/dL), elevated triglycerides (>150 mg/dL) and low HDL (men: <40 mg/dL, women: <50 mg/dL). In cross-sectional analyses, we examined whether metabolic syndrome and its components were associated with presence of symptomatic hand OA using logistic regression. In longitudinal analyses, we examined the associations between metabolic syndrome and incident symptomatic hand OA at exam 7. We adjusted for age and sex.

Results: Of the 748 participants who fulfilled the inclusion criteria, 74 (9.9%) had symptomatic hand OA. Participants with symptomatic hand OA were older than those without (mean (SD) 62.2 (5.9) vs. 57.7 (6.0) years) and more likely to be women (75.7% vs. 51.0%). There was no significant association between metabolic syndrome and symptomatic hand OA (Table). The strength of association between metabolic syndrome and symptomatic hand OA was attenuated when we adjusted for body mass index (BMI) (cross-sectional association: OR 1.19, 95% CI 0.68-2.10). When evaluating the individual components of metabolic syndrome separately, we found a significant association between central obesity and symptomatic hand OA in the adjusted cross-sectional analyses (Table). In the longitudinal analyses, we found a statistically significantly lower risk of incident symptomatic hand OA associated with elevated triglycerides (Table). The association remained after adjustment for lipid-lowering treatment (data not shown). Similar results were found when we included BMI in the adjusted models (data not shown).

Conclusion: Metabolic syndrome was not associated with higher probability of presence or development of hand OA. If anything, we observed a lower probability of incident symptomatic hand OA in participants with high triglycerides.


Table. Associations between metabolic syndrome and hand OA.

Frequency of metabolic syndrome (%)

Logistic regression

OR (95% CI)

No hand OA

Hand OA

Crude analyses

Adjusted for age and sex

Cross-sectional analyses 1

Metabolic syndrome

39.0

48.6

1.48 (0.91-2.40)

1.44 (0.87-2.38)

Central obesity

64.2

79.7

2.19 (1.22-3.94)

2.24 (1.22-4.12)

Hypertension

40.2

50.0

1.49 (0.92-2.41)

1.27 (0.77-2.11)

High blood-glucose

27.5

24.3

0.85 (0.49-1.48)

0.89 (0.49-1.61)

High triglycerides

33.4

33.8

1.02 (0.61-1.69)

1.01 (0.60-1.73)

Low HDL

64.1

70.3

1.32 (0.78-2.23)

1.30 (0.75-2.23)

Longitudinal analyses (only those without hand OA at baseline were included) 2

Metabolic syndrome

38.6

31.5

0.73 (0.45-1.18)

0.77 (0.47-1.25)

Central obesity

63.5

59.8

0.85 (0.56-1.43)

0.90 (0.56-1.43)

Hypertension

37.4

41.3

1.18 (0.74-1.86)

1.24 (0.77-1.20)

High blood-glucose

28.0

18.7

0.59 (0.33-1.04)

0.64 (0.35-1.14)

High triglycerides

34.0

21.7

0.54 (0.32-0.92)

0.56 (0.33-0.96)

Low HDL

64.9

55.4

0.67 (0.43-1.06)

0.67 (0.42-1.05)

1 n=674 and n=74 without and with symptomatic hand OA at exam 5, respectively,

2 n=430 and n=92 without and with incident symptomatic hand OA at exam 7, respectively (n=152 lost to follow-up),



Disclosure:

I. K. Haugen,
None;

V. Ramachandran,
None;

D. Misra,
None;

T. Neogi,
None;

J. Niu,
None;

Y. Zhang,
None;

D. T. Felson,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-association-between-metabolic-syndrome-and-hand-osteoarthritis-data-from-the-framingham-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology